Xiang M, Yang X, Ren S, Du F, et al. Anlotinib Combined with S-1 in Third- or Later-Line Stage IV Non-Small Cell Lung Cancer Treatment: A Phase II Clinical Trial. Oncologist 2021 Aug 22. doi: 10.1002/onco.13950.
PMID: 34423518